Search General Info
Search Education
Search Partnering Companies
photo
Speaker

Kanad Das

EXECUTIVE DIRECTOR, BI VENTURE FUND, BOEHRINGER INGELHEIM
Redwood City, California, United States
Kanad joined Boehringer Ingelheim from Merck (MSD) where he was Director, Business Development and Licensing in their West Coast Innovation Hub. He evaluated assets in Immuno-Oncology, Cardiovascular and Metabolic Diseases and Ophthalmology in the preclinical space up to human proof of concept. Kanad started his career at Genentech as a post-doctoral fellow. He then worked as a medicinal chemist at KAI Pharmaceuticals, where he was an inventor of Parsabiv, approved in 2017 for the treatment of Secondary Hyperparathyroidism. After KAI, Kanad worked at Stanford University’s SPARK program, an academic accelerator designed to take basic science discoveries and bring them to fundable assets. He received his PhD in Chemistry from the University of Massachusetts, Amherst and a B.Sc. in Chemistry from UC Berkeley.
Speaking In
3:00 PM - 3:45 PM (EDT)
Monday, June 14

In the current environment, nascent biotech companies can raise funding from a variety of…